Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer
Rishi S Kotecha, Ushma D Wadia, Peter Jacoby, Anne L Ryan, Christopher C Blyth, Anthony D Keil, Nicholas G Gottardo, Catherine H Cole, Ian G Barr, Peter C Richmond
CANCER MEDICINE | WILEY | Published : 2016
Influenza is associated with significant morbidity and mortality in children receiving therapy for cancer, yet recommendation for, and uptake of the seasonal vaccine remains poor. One hundred children undergoing treatment for cancer were vaccinated with the trivalent inactivated influenza vaccine according to national guidelines in 2010 and 2011. Influenza-specific hemagglutinin inhibition antibody titers were performed on blood samples taken prior to each vaccination and 4 weeks following the final vaccination. A nasopharyngeal aspirate for influenza was performed on all children who developed an influenza-like illness. Following vaccination, seroprotection and seroconversion rates were 55 ..View full abstract
This study was funded by the Princess Margaret Hospital Foundation.